Botulin Toxin Use in Rosacea and Facial Flushing Treatment
Botulinum toxin (BTX) is a neurotoxin derived from the Clostridium botulinum bacterium that inhibits the release of acetylcholine at the neuromuscular junction level whose effects has been used for many years to treat a variety of muscular/neuromuscular conditions and more recently also for cosmetic use. BTX has experimented in some dermatological conditions, which include Rosacea and facial flushing treatment with good results. The complex mechanism underlying those results is not completely understood but was proposed a release inhibition of acetylcholine from peripheral autonomic nerves of the cutaneous vasodilatory system combined with the blockade substance P and calcitonin gene-related peptide (CGRP) thus modulating blood vessel dilatation. We analysed the published data on BTX off label applications rosacea and flushing retrieved from PubMed.
Top-30
Journals
|
1
|
|
|
Medicina
1 publication, 5%
|
|
|
Dermatology and Therapy
1 publication, 5%
|
|
|
Journal of Allergy and Clinical Immunology
1 publication, 5%
|
|
|
Journal of the European Academy of Dermatology and Venereology
1 publication, 5%
|
|
|
Dermatological Reviews
1 publication, 5%
|
|
|
Journal of Cosmetic and Laser Therapy
1 publication, 5%
|
|
|
Patient Preference and Adherence
1 publication, 5%
|
|
|
Plasticheskaya khirurgiya i esteticheskaya meditsina
1 publication, 5%
|
|
|
Russian Journal of Skin and Venereal Diseases
1 publication, 5%
|
|
|
Cureus
1 publication, 5%
|
|
|
Journal of Cutaneous Medicine and Surgery
1 publication, 5%
|
|
|
Journal of Cosmetic Dermatology
1 publication, 5%
|
|
|
Frontiers in Medicine
1 publication, 5%
|
|
|
Cosmoderma
1 publication, 5%
|
|
|
JAMA Dermatology
1 publication, 5%
|
|
|
Frontiers in Immunology
1 publication, 5%
|
|
|
Dermatologic Surgery
1 publication, 5%
|
|
|
Journal of Clinical Medicine
1 publication, 5%
|
|
|
Journal of Cutaneous and Aesthetic Surgery
1 publication, 5%
|
|
|
1
|
Publishers
|
1
2
3
4
|
|
|
Wiley
4 publications, 20%
|
|
|
MDPI
2 publications, 10%
|
|
|
Springer Nature
2 publications, 10%
|
|
|
Taylor & Francis
2 publications, 10%
|
|
|
Frontiers Media S.A.
2 publications, 10%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
2 publications, 10%
|
|
|
Elsevier
1 publication, 5%
|
|
|
Media Sphere Publishing House
1 publication, 5%
|
|
|
Eco-Vector LLC
1 publication, 5%
|
|
|
SAGE
1 publication, 5%
|
|
|
Scientific Scholar
1 publication, 5%
|
|
|
American Medical Association (AMA)
1 publication, 5%
|
|
|
1
2
3
4
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.